Clinical Trial Update: Nuedexta in Treatment-Resistant Major Depression [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Nuedexta (dextromethorphan/quinidine) for treatment-resistant major depressive disorder. Results were posted in June 2018 after study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• NUEDEXTA (DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE)

Snippet

Sponsor: James Murrough | Conditions: Major Depressive Disorder, Treatment Resistant | Phase 2 | Status: COMPLETED | Results posted: 2018-06-11